R.H. Dinel Investment Counsel, Inc. Gilead Sciences, Inc. Transaction History

R.H. Dinel Investment Counsel, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$57.72 - $65.01 $955,266 - $1.08 Million	-16,550 Closed	0 $0
Q3 2021 Oct 20, 2021	SELL	$67.69 - $73.03 $121,842 - $131,454	-1,800 Reduced 9.81%	16,550 $1.16 Million
Q2 2020 Jul 23, 2020	BUY	$72.34 - $84.0 $515,422 - $598,500	7,125 Added 63.47%	18,350 $1.41 Million
Q4 2018 Jan 18, 2019	BUY	$60.54 - $79.0 $679,561 - $886,775	11,225 New	11,225 $702,000

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $85.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of R.H. Dinel Investment Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on R.H. Dinel Investment Counsel, Inc. with notifications on news.